- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Finjan Files a Complaint Against Rapid7 for Patent Infringement
Finjan Holdings (NASDAQ:FNJN) announced that it has filed a patent infringement lawsuit against Rapid7 in the U.S. District Court for the District of Delaware. Finjan, a cybersecurity company said that the step was taken after two years of efforts to resolve the dispute with Rapid7. As quoted in the press release: Finjan filed the Complaint …
Finjan Holdings (NASDAQ:FNJN) announced that it has filed a patent infringement lawsuit against Rapid7 in the U.S. District Court for the District of Delaware.
Finjan, a cybersecurity company said that the step was taken after two years of efforts to resolve the dispute with Rapid7.
As quoted in the press release:
Finjan filed the Complaint (Case No. 1-18-cv-01519), on October 1, 2018, and alleges that Rapid7’s products and services infringe at least seven U.S. Finjan patents. Specifically, Finjan asserts that Rapid7’s InsightIDR, InsightVM (Nexpose), InsightAppSec, AppSpider, Metasploit and Komand technologies, including Rapid7 Insight Platform products (collectively “Accused Products”) infringe U.S. Patent Nos. 7,613,918, 7,757,289, 7,975,305, 8,079,086, 8,141,154, 8,225,408 and 8,677,494 (collectively “Asserted Patents”). Finjan is seeking, among other things, a jury trial, past damages not less than a reasonable royalty, enhanced damages for willful, wanton and deliberate infringement, and reasonable attorneys’ fees and costs for infringement of each of the Asserted Patents, as well as preliminary and permanent injunctive relief against Rapid7 and those in privity with them, from infringing and inducing the infringement of the ‘305, ‘408, ‘289 and ‘154 Patents.
“Since 2014, Finjan has been committed to our Best Practices, which are posted on our website along with a list of our patents, all of which serve to inform players in the security space of our patent rights and how we intend to preserve the value of our patents,” stated Julie Mar-Spinola, CIPO and VP, Legal Operations for the Finjan companies. “Time and again the Federal Circuit, District Courts, and the USPTO, including its Patent Trial and Appeal Board, have validated the enforceability of Finjan’s patents, which have generated licensing and settlement fees of more the $350M to date. It is perplexing, at best, to understand why a prospective licensee would rather ignore our efforts to negotiate a fair valued license and choose the costlier risk of a patent lawsuit with Finjan.”
Finjan has pending infringement lawsuits and appeals against Palo Alto Networks, ESET and its affiliates, Cisco Systems, Inc., SonicWall, Inc., Bitdefender and its affiliates, Juniper Networks, Zscaler, Inc. and Check Point and its affiliates, relating to, collectively, more than 20 patents in the Finjan portfolio. The court dockets for the foregoing cases are publicly available on the Public Access to Court Electronic Records (PACER) website, www.pacer.gov, which is operated by the Administrative Office of the U.S. Courts.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.